Canadian Phase Onward Inc. (CPO) was opened in 2004 due to the growing interest from pharmaceutical companies in more non-hospital based Canadian sites to participate in their diverse clinical trials. CPO is located at the same site, and operates in tandem with, the Polyclinic Family and Specialty Medicine Facility, resulting in a referral network of more than 50 specialists and family physicians.
CPO boasts Dr. Lew Pliamm BSc, MD, CCFP, FCFP as both its Medical Director and principal investigator. Dr. Lew Pliamm has over 15 years of experience in Phase 2, 3 and 4 clinical research trials in a wide range of all diagnostic areas including but not limited to smoking cessation, diabetes, erectile dysfunction, hypertension, cardiovascular (general), migraine, weight loss, GERD, irritable bowel syndrome, constipation, metabolic syndrome, insomnia, pain relief, fibromyalgia, COPD, asthma, schizophrenia, and depression. CPO also has experience in vaccine studies.
CPO has been one of the sites of choice by some of the largest pharmaceutical companies including Janssen Inc., Merck Frosst, GSK, Pfizer, Novartis, Sanofi, AstraZeneca, Otsuka, and Bayer. CPO has also been one of the sites of choice for some of the largest CROs including but not limited to Covance, INC Research, and Parexel.
CPO also focuses on the benefits that participating in these clinical trials may offer to our patients, including more intensive physician care, potential access to treatment options that may not otherwise be available, and free medications and testing. This is a great complement to the Polyclinic Family and Specialty Medicine Facility.